Uncovering Cell Signaling Pathways Transforming Medicine
About Cellazon
Our History
Our Mission & Values
Our Technology
Cellazon was founded on April 7th, 2025 with the goal of offering its expertise in advanced AI, Machine Learning (ML), for multi-omics computational data analysis to help develop better Dx biomarkers and therapeutics through collaborations with precision medicine teams with access to patient-derived databases.
Our Technology
Our Mission & Values
Our Technology
Cellazon's expertise in computational analysis uncovers the signaling pathways that drive cell-to-cell communication in disease.By identifying novel therapeutic targets and biomarkers, we aim to transform the treatment landscape across a range of indications. Leveraging our proprietary in-vivo immune cell engineering platform, we aim to d
Cellazon's expertise in computational analysis uncovers the signaling pathways that drive cell-to-cell communication in disease.By identifying novel therapeutic targets and biomarkers, we aim to transform the treatment landscape across a range of indications. Leveraging our proprietary in-vivo immune cell engineering platform, we aim to design and develop effective cell therapies for these targets.
Our Mission & Values
Our Mission & Values
Our Mission & Values
At Cellazon, we are committed to ethical conduct in all we do and united by a shared mission to redefine disease biology and unlock new and highly personalized therapeutic possibilities that are safe, effective, and accessible to all.